issues on separation
How can one reconcile use of polyclonal standards for free light chains when interpreting individual samples, which are similar to monoclonal bands? This is a conceptual conundrum as samples from patients with multiple sclerosis typically display multiple "mini" monoclonal bands. Thus, it is true that one is not strictly comparing like with like.
Which has better resolution, electrophoresis or focusing? Clearly the latter, which is why the Consensus neurologists also "prefer" this method of separation for antibody molecules (2, 3 ) .
There are currently two Food and Drug Administra- 
issues in qualitative/quantitative analysis
What is the clearest advantage of quantitative analysis of light chains? As Fischer et al. rightly state, this is to "follow changes" (1 ), e.g., in response to therapy and possibly prognosis (7 ) . To reiterate, however: for diagnosis, qualitative analysis is much preferred. In terms of basic pathophysiology, there are clearly quantitative changes during the course of multiple sclerosis, whereas in isoelectric focusing, patients have a so-called "fingerprint" pattern that typically does not change (8 ) .
Who else has noticed this dichotomy between diagnosis and therapy? This has been debated for many years by hematologists dealing with myeloma, and many accept that qualitative analysis is better for diagnosis, whereas quantitative analysis is better for monitoring therapy. This has been confirmed in large survey studies (9 ) . One could go further and say that for many other serum proteins, qualitative analysis is a necessary adjunct to a quantitative analysis (10 ) .
What is the best way to keep "uncertainty in result interpretation to a minimum" (1 )? The answer must be reliable quality control. The IgG patterns after focusing should be classified according to one of the five recognized types (2 ), but in most people's experience, ϳ80% are normal (polyclonal). There is an additional trade-off between qualitative analysis with "uncertain" interpretation vs quantitative analysis, which is certainly less sensitive/specific.
issues in sensitivity
What is the basic technique involved in the production of antibodies against free light chains? With extensive adsorption, one ends up with not only lower affinity but also, as is clearly demonstrated yet again in this study with lower sensitivity. An alternative approach is to use "unadsorbed" monoclonal antibodies (11 ) . These can match the specificity of the current antibodies but without the heavy cost of poor sensitivity.
How useful is a quantitative test in which one third of normal patients have values that are indistinguishable from the background values? Again, further work is required to improve sensitivity.
How close is the sensitivity for the quotient (CSF concentrations divided by serum concentrations) of free light chains (94%) vs the "gold standard" (electrophoresis) chosen by Fischer et al. (1 ) , which the authors set by definition to 100%? Beyond the need for focusing as the Consensus gold standard, one would raise the obvious supplementary question: What would ROC analysis show, using not the quotient but the absolute concentrations of CSF free light chains?
How useful is a hyperbolic curve for quotients in these circumstances? In multiple sclerosis, the barrier function for the majority of patients is normal or shows only minor degrees of change (2 ) . Therefore, a hyperbolic curve is relevant when there are much higher concentrations of CSF total protein.
issues in specificity
Have others noticed "false" positives as well? The best examples are probably Sindic and Laterre (12 ) with similar findings by Lamers et al. (13 ) . They each showed abnormalities in noninflammatory brain diseases, e.g., amyotrophic lateral sclerosis.
What are the pros and cons of "in-gel" immunofixation vs immunoblotting on nitrocellulose (or other fiber) membranes? This is a protracted story, but the fundamental step is that proteins bind directly to membranes. However, for in-gel fixation to work, the antibody must first precipitate the relevant protein before it can be "visualized" by any staining (14 ) . Another advantage of in-gel immunofixation is that it avoids the use of nitrocellulose, but the problem of "pro-zone" (IgG concentrations too high) remains.
Last, but certainly not least, can one presume that there is no additional benefit by analyzing free light chain bands [by isoelectric focusing] compared with the nephelometric quantification used in this study (1 )? Yet again, there is not only much additional information from the qualitative technique (13 ) , but this also loops back to the first general point above, namely, that qualitative analysis of CSF IgG is better than quantitative analysis.
I apologize if I have raised more questions than answers, but then that is what makes the future more interesting. We should probably have an International Consensus on measuring free light chains and their calibrators: perhaps a topic for a future Editorial (15 )?
